Cargando…
Blockade of EP4 by ASP7657 Modulates Myeloid Cell Differentiation In Vivo and Enhances the Antitumor Effect of Radiotherapy
The tumor microenvironment (TME) is thought to influence the antitumor efficacy of immuno-oncology agents through various products of both tumor and stromal cells. One immune-suppressive factor is prostaglandin E(2) (PGE(2)), a lipid mediator whose biosynthesis is regulated by ubiquitously expressed...
Autores principales: | Nishibata, Toshihide, Amino, Nobuaki, Tanaka-Kado, Ruriko, Tsujimoto, Susumu, Kawashima, Tomoko, Konagai, Satoshi, Suzuki, Tomoyuki, Takeuchi, Masahiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10697779/ http://dx.doi.org/10.1155/2023/7133726 |
Ejemplares similares
-
Myocardial Infarction and AGT p.Thr174Met Polymorphism: A Meta-Analysis of 7657 Subjects
por: Li, Yan-yan, et al.
Publicado: (2021) -
Dual Blockade of EP2 and EP4 Signaling is Required for Optimal Immune Activation and Antitumor Activity Against Prostaglandin-Expressing Tumors
por: Francica, Brian J., et al.
Publicado: (2023) -
Targeting Myeloid-Derived Suppressor Cells to Enhance the Antitumor Efficacy of Immune Checkpoint Blockade Therapy
por: Li, Xueyan, et al.
Publicado: (2021) -
CDP7657, an anti-CD40L antibody lacking an Fc domain, inhibits CD40L-dependent immune responses without thrombotic complications: an in vivo study
por: Shock, Anthony, et al.
Publicado: (2015) -
Antibacterial mechanism of the Asp-Asp-Asp-Tyr peptide
por: Zhuang, Shanshan, et al.
Publicado: (2022)